PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19013351-0	2008	Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.	Tigecycline	62-73	CTX-M-15	Klebsiella pneumoniae	103-135	
19013351-7	2008	Limited agreement (<80%) was found between the broth microdilution and the Etest methods when determining the in-vitro activity of tigecycline against ESBL- producing K. pneumoniae and K. oxytoca.	Tigecycline	134-145	CTX-M-15	Klebsiella pneumoniae	154-158	
18787741-0	2008	In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.	Tigecycline	21-32	CTX-M-15	Klebsiella pneumoniae	62-94	
18787741-2	2008	In this study, we evaluated the in vitro antimicrobial activity of tigecycline against ESBL-producing Enterobacteriaceae, including Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.	Tigecycline	67-78	CTX-M-15	Klebsiella pneumoniae	87-91	
18787741-4	2008	The in vitro activity of tigecycline against these ESBL producers was tested by use of Etest strips.	Tigecycline	25-36	CTX-M-15	Klebsiella pneumoniae	51-55	
18787741-6	2008	CONCLUSIONS: Tigecycline, a new semisynthetic glycylcycline, may be considered an alternative drug of choice for patients infected with ESBL-producing bacteria.	Tigecycline	13-24	CTX-M-15	Klebsiella pneumoniae	136-140	
30068997-5	2018	This study identified 67 eravacycline-nonsusceptible isolates; among the extended-spectrum beta-lactamase (ESBL)-positive isolates, eravacycline-nonsusceptible isolates were detected more frequently than tigecycline-nonsusceptible isolates (21.7% vs. 9.4%, p = 0.001).	Tigecycline	204-215	CTX-M-15	Klebsiella pneumoniae	73-105	
16870760-12	2006	Tigecycline, lacking cross-resistance with other compounds, could represent an opportunity to reduce the intensity of selection for ESBL-producing organisms derived from the use of other antimicrobial agents.	Tigecycline	0-11	CTX-M-15	Klebsiella pneumoniae	132-136